# VMAT2 Inhibitors: Valbenazine (Ingrezza) and Deutetrabenazine (Austedo)

An episode of [PsychRounds: The Psychiatry Podcast](https://invisiblenetwork.ai/podcast/1719888462), 21 Mar 2026, 17 min.

Audio: https://anchor.fm/s/eb936048/podcast/play/116727659/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-2-11%2F419751627-44100-2-e2a85ebd5c645.m4a

Welcome back! Today we are featuring the two FDA-approved medications for tardive dyskinesia, the VMAT2 inhibitors Valbenazine (Ingrezza) and Deutetrabenazine (Austedo). References: https://pubmed.ncbi.nlm.nih.gov/41626799/ https://www.ncbi.nlm.nih.gov/books/NBK548187/ https://pubmed.ncbi.nlm.nih.gov/41626799/

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them.